MAP7D2 interacts with the MYH9 protein to protect it from ubiquitin-mediated degradation, subsequently reducing the secretion of HMGB1 to inhibit the infiltration of CD8+ cytotoxic T lymphocytes in microsatellite-stable colorectal cancer [54]. Here, MAP7D2 is linked to colorectal cancer.